Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

SG Americas Securities LLC reduced its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 70.7% during the fourth quarter, ...

Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.

A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience ...

For superior performance in quality, delivery, innovation and partnership related to fluid dispensing systems used in ...

Skyrocketing technology requirements for AI data centers is expected to drive market demand for Photonic Integrated Circuits ...

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances Jabil's ...

Chicago Partners Investment Group LLC purchased a new stake in Jabil Inc. (NYSE:JBL – Free Report) during the 4th quarter, ...